Child in Liverpool dies after contracting measles
A statement from the Alder Hey Children's NHS Foundation Trust said: 'To respect patient confidentiality, we can't comment on individual cases.
'We are concerned about the increasing number of children and young people who are contracting measles. Measles is a highly contagious viral illness which can cause children to be seriously unwell, requiring hospital treatment, and in rare cases, death.
'The number of children being treated at Alder Hey for effects and complications of measles is increasing (we have treated 17 since June).
'We treat children with a range of conditions and illnesses in our hospital, including those with compromised immunity due to other health issues, making them more susceptible to infections, including measles.
'We can prevent people, including children, from contracting measles through vaccination. Please protect yourself and vulnerable children and young people by ensuring you are fully vaccinated.'
The child is believed to be the second to succumb to an acute measles infection in Britain this decade.
It comes after a Royal College of Paediatrics and Child Health (RCPCH) report released earlier this month determined uptake of vaccines in the UK has stalled over the last decade and is, in many cases, declining.
None of the routine childhood vaccinations have met the target for 95% coverage since 2021, meaning youngsters are at risk of catching illnesses such as measles, meningitis and whooping cough.
The report said while some families are hesitant to vaccinate due to fears about the jabs, many face issues that could be resolved with more support, including difficulties booking and attending appointments and a lack of continuity of NHS care, with many parents seeing a different GP or clinician at each visit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
an hour ago
- Glasgow Times
DIY heart monitor rolled out to cut hospital waiting lists
Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent out to patients in the post for them to attach themselves at home. The device looks like a small patch which is stuck to the skin, while traditional devices see patients hooked up to numerous wires and monitors. After the new tool is worn for a few days, patients can post the device back – which will cut out the need for appointments to fit and remove the equipment. The information from the monitor is then assessed using an artificial intelligence (AI) tool, Cardiologs, which produces a report which is then assessed by either a physiologist or a doctor. It can be used to investigate conditions include atrial fibrillation, tachycardia or heart blocks. Frimley Health NHS Foundation Trust is the first hospital in the country to roll out the device, with hopes that the device will soon be used across other NHS trusts. The Trust said it will still use traditional devices, known as Holter monitors, on some patients who are in hospital, but many of those who are outside of hospital will be able to access the new ePatch, which is made by Philips, to use in the comfort of their own homes. The new ePatch (right) is said to be more convenient than a traditional Holter monitor (left) (Frimley Health NHS Foundation Trust/PA) It has estimated that the use of the patches will double its productivity levels for diagnosing heart rhythm problems. Dr Iain Sim, consultant cardiac electrophysiologist, told the PA news agency: 'The purpose of the device is to record the heart rhythm – to collect electrical signals from the heart – and to try to understand a bit about the patient and what they are experiencing and whether that can be explained by their heart rhythm. 'This smaller device allows us to measure at the moment up to 10 days 'The benefits of it are that it is smaller and more convenient, rather than different wires all over the place. 'We are able to put them on faster and we're able to reduce our turnaround times for reports and to get results back to patients faster.' The patch can monitor a person's heart rate for 10 to 14 days (Frimley Health NHS Foundation Trust/PA) He said that traditional Holter monitors are attached by trained physiologists but there is a shortage of these staff members at present. 'Because these are more straightforward, we've got specialist nurses who can be quite easily trained to apply them,' he added. Suzanne Jordan, associate director for medicine at Frimley Health, said the patches can even be sent out to patients for them to attach themselves. The feedback from the monitors are developed into reports for medics which are categorised in a traffic light system, she said. 'Green is perfectly fine – within normal limits; amber may need a clinician to review the report; red means potentially significant pauses or arrhythmia that need kind of an urgent review,' she said. 'It's been really positive – staff and patients really like it. 'We can post the patches to patients – there's explicit instructions there in terms of how to put it on, what to do if there's a problem, and also just to send it back as well. 'Once it comes back, it gets downloaded and the turnaround times are great.' Frimley Health NHS Foundation Trust said the move has been welcomed by patients and staff (Frimley Health NHS Foundation Trust/PA) Ms Jordan added: 'If you think of the bigger picture, it means that we're going to be able to manage our patients quickly. 'We've been running clinics by seeing maybe 30 patients in one day, whereas before, we were probably seeing 14 maximum – so we've kind of doubled our productivity. Asked about the conditions which will be monitored with the devices, Dr Sim added: 'Atrial fibrillation (AF) is a really important and common condition that we pick up with these devices, and we're increasingly looking at whether we can use them to help detect AF that's not symptomatic, and whether people are increased risk of stroke that we don't know about. 'The other conditions would relate to other forms of types of tachycardia, so fast heart rates, or episodes of very slow heart rates, such as heart blocks of different degrees, where patients may have palpitations or they may have fainting or syncope. 'So it allows us to monitor all of those heart rhythms.' On the use of AI to review the data from the monitors, he added: 'I think it's natural for everyone to be concerned whenever you put the term 'AI' into something, but these are pretty well tested algorithms that still have human oversight.' Mark Leftwich, managing director for Philips UK and Ireland, said: 'We're really excited to be working with Frimley Health to make heart monitoring easier and more comfortable for patients. 'Studies show Philips ePatch can spot up to 2.5 times more clinically relevant heart rhythm issues than the traditional Holter monitors – so not only is it more comfortable to wear, it can actually help catch issues that might have been missed before.'
South Wales Guardian
an hour ago
- South Wales Guardian
DIY heart monitor rolled out to cut hospital waiting lists
Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent out to patients in the post for them to attach themselves at home. The device looks like a small patch which is stuck to the skin, while traditional devices see patients hooked up to numerous wires and monitors. After the new tool is worn for a few days, patients can post the device back – which will cut out the need for appointments to fit and remove the equipment. The information from the monitor is then assessed using an artificial intelligence (AI) tool, Cardiologs, which produces a report which is then assessed by either a physiologist or a doctor. It can be used to investigate conditions include atrial fibrillation, tachycardia or heart blocks. Frimley Health NHS Foundation Trust is the first hospital in the country to roll out the device, with hopes that the device will soon be used across other NHS trusts. The Trust said it will still use traditional devices, known as Holter monitors, on some patients who are in hospital, but many of those who are outside of hospital will be able to access the new ePatch, which is made by Philips, to use in the comfort of their own homes. It has estimated that the use of the patches will double its productivity levels for diagnosing heart rhythm problems. Dr Iain Sim, consultant cardiac electrophysiologist, told the PA news agency: 'The purpose of the device is to record the heart rhythm – to collect electrical signals from the heart – and to try to understand a bit about the patient and what they are experiencing and whether that can be explained by their heart rhythm. 'This smaller device allows us to measure at the moment up to 10 days 'The benefits of it are that it is smaller and more convenient, rather than different wires all over the place. 'We are able to put them on faster and we're able to reduce our turnaround times for reports and to get results back to patients faster.' He said that traditional Holter monitors are attached by trained physiologists but there is a shortage of these staff members at present. 'Because these are more straightforward, we've got specialist nurses who can be quite easily trained to apply them,' he added. Suzanne Jordan, associate director for medicine at Frimley Health, said the patches can even be sent out to patients for them to attach themselves. The feedback from the monitors are developed into reports for medics which are categorised in a traffic light system, she said. 'Green is perfectly fine – within normal limits; amber may need a clinician to review the report; red means potentially significant pauses or arrhythmia that need kind of an urgent review,' she said. 'It's been really positive – staff and patients really like it. 'We can post the patches to patients – there's explicit instructions there in terms of how to put it on, what to do if there's a problem, and also just to send it back as well. 'Once it comes back, it gets downloaded and the turnaround times are great.' Ms Jordan added: 'If you think of the bigger picture, it means that we're going to be able to manage our patients quickly. 'We've been running clinics by seeing maybe 30 patients in one day, whereas before, we were probably seeing 14 maximum – so we've kind of doubled our productivity. Asked about the conditions which will be monitored with the devices, Dr Sim added: 'Atrial fibrillation (AF) is a really important and common condition that we pick up with these devices, and we're increasingly looking at whether we can use them to help detect AF that's not symptomatic, and whether people are increased risk of stroke that we don't know about. 'The other conditions would relate to other forms of types of tachycardia, so fast heart rates, or episodes of very slow heart rates, such as heart blocks of different degrees, where patients may have palpitations or they may have fainting or syncope. 'So it allows us to monitor all of those heart rhythms.' On the use of AI to review the data from the monitors, he added: 'I think it's natural for everyone to be concerned whenever you put the term 'AI' into something, but these are pretty well tested algorithms that still have human oversight.' Mark Leftwich, managing director for Philips UK and Ireland, said: 'We're really excited to be working with Frimley Health to make heart monitoring easier and more comfortable for patients. 'Studies show Philips ePatch can spot up to 2.5 times more clinically relevant heart rhythm issues than the traditional Holter monitors – so not only is it more comfortable to wear, it can actually help catch issues that might have been missed before.'
Rhyl Journal
an hour ago
- Rhyl Journal
DIY heart monitor rolled out to cut hospital waiting lists
Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent out to patients in the post for them to attach themselves at home. The device looks like a small patch which is stuck to the skin, while traditional devices see patients hooked up to numerous wires and monitors. After the new tool is worn for a few days, patients can post the device back – which will cut out the need for appointments to fit and remove the equipment. The information from the monitor is then assessed using an artificial intelligence (AI) tool, Cardiologs, which produces a report which is then assessed by either a physiologist or a doctor. It can be used to investigate conditions include atrial fibrillation, tachycardia or heart blocks. Frimley Health NHS Foundation Trust is the first hospital in the country to roll out the device, with hopes that the device will soon be used across other NHS trusts. The Trust said it will still use traditional devices, known as Holter monitors, on some patients who are in hospital, but many of those who are outside of hospital will be able to access the new ePatch, which is made by Philips, to use in the comfort of their own homes. It has estimated that the use of the patches will double its productivity levels for diagnosing heart rhythm problems. Dr Iain Sim, consultant cardiac electrophysiologist, told the PA news agency: 'The purpose of the device is to record the heart rhythm – to collect electrical signals from the heart – and to try to understand a bit about the patient and what they are experiencing and whether that can be explained by their heart rhythm. 'This smaller device allows us to measure at the moment up to 10 days 'The benefits of it are that it is smaller and more convenient, rather than different wires all over the place. 'We are able to put them on faster and we're able to reduce our turnaround times for reports and to get results back to patients faster.' He said that traditional Holter monitors are attached by trained physiologists but there is a shortage of these staff members at present. 'Because these are more straightforward, we've got specialist nurses who can be quite easily trained to apply them,' he added. Suzanne Jordan, associate director for medicine at Frimley Health, said the patches can even be sent out to patients for them to attach themselves. The feedback from the monitors are developed into reports for medics which are categorised in a traffic light system, she said. 'Green is perfectly fine – within normal limits; amber may need a clinician to review the report; red means potentially significant pauses or arrhythmia that need kind of an urgent review,' she said. 'It's been really positive – staff and patients really like it. 'We can post the patches to patients – there's explicit instructions there in terms of how to put it on, what to do if there's a problem, and also just to send it back as well. 'Once it comes back, it gets downloaded and the turnaround times are great.' Ms Jordan added: 'If you think of the bigger picture, it means that we're going to be able to manage our patients quickly. 'We've been running clinics by seeing maybe 30 patients in one day, whereas before, we were probably seeing 14 maximum – so we've kind of doubled our productivity. Asked about the conditions which will be monitored with the devices, Dr Sim added: 'Atrial fibrillation (AF) is a really important and common condition that we pick up with these devices, and we're increasingly looking at whether we can use them to help detect AF that's not symptomatic, and whether people are increased risk of stroke that we don't know about. 'The other conditions would relate to other forms of types of tachycardia, so fast heart rates, or episodes of very slow heart rates, such as heart blocks of different degrees, where patients may have palpitations or they may have fainting or syncope. 'So it allows us to monitor all of those heart rhythms.' On the use of AI to review the data from the monitors, he added: 'I think it's natural for everyone to be concerned whenever you put the term 'AI' into something, but these are pretty well tested algorithms that still have human oversight.' Mark Leftwich, managing director for Philips UK and Ireland, said: 'We're really excited to be working with Frimley Health to make heart monitoring easier and more comfortable for patients. 'Studies show Philips ePatch can spot up to 2.5 times more clinically relevant heart rhythm issues than the traditional Holter monitors – so not only is it more comfortable to wear, it can actually help catch issues that might have been missed before.'
